Cargando…
Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by ApoA-I(Milano)
Recombinant-ApoA-I(M) (rApoA-I(M)) administration has been shown to regress and stabilize atherosclerotic plaques. However, the mechanisms responsible for these beneficial effects are not fully understood. The aims of the present study were to define whether the benefits of rApoA-I(M) treatment were...
Autores principales: | Cimmino, Giovanni, Ibanez, Borja, Vilahur, Gemma, Speidl, Walter S, Fuster, Valentin, Badimon, Lina, Badimon, Juan J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516480/ https://www.ncbi.nlm.nih.gov/pubmed/19120689 http://dx.doi.org/10.1111/j.1582-4934.2008.00614.x |
Ejemplares similares
-
Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent
por: Lebherz, Corinna, et al.
Publicado: (2007) -
Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor
por: Vilahur, Gemma, et al.
Publicado: (2014) -
Atherosclerosis and Thrombosis: Insights from Large Animal Models
por: Vilahur, Gemma, et al.
Publicado: (2011) -
Unraveling the Complexity of HDL Remodeling: On the Hunt to Restore HDL Quality
por: Schoch, Leonie, et al.
Publicado: (2021) -
Advances in HDL: Much More than Lipid Transporters
por: Ben-Aicha, Soumaya, et al.
Publicado: (2020)